1Torbicki A, Konstantinides S, Perrier A, et al. Guidelines on the diagnosis and management of acute pulmonary embolism [ J ]. Eur Heart J, 2008, 29 ( 18 ) :2276 - 2315.
2陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
3陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
4Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteris- tics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR ( Muhicenter Emergency Medicine Pulmonary Embol- ism in the Real World Registry)[ J]. J Am Coil Cardiol,2011,57: 700 - 706.
9de Bonis S, Rendin a D, Vargas G, et al. Predictors of in -hospital and Ion g-term clinical outcome in elderly patient swithm as sive pulmonary embolism receiving thrombolytic therapy[ J]. J Am Geri- atr Soc, 2008, 56(12):2273-2277.
5Arnalich F, Maldifassi MC,Ciria E,et al. Plasma levels of mito- chondrial and nuclear DNA in patients with massive pulmonary em- bolism in the emergency department: a prospective cohort study [ J ]. Crit Care,2013,17 ( 3 ) : R90.
6Dellas C, Puls M, Lankeit M, et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism [ J ]. J Am Coil Cardiol,2010,55(19) :2150 -2157.
7Ozbek M, Erdogan M, Dogan M, et al. Serum heart-type fatty acid binding protein levels in acromegaly patients[ J ]. J Endocrinol In- vest,2011,34 ( 8 ) :576 - 579.
8Boscheri A, Wunderlich C, Langer M, et al. Correlation of heart- type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intezanediate risk[J]. Am Heart J,2010,160(2) :294 -300.
9Orfanos SE, Zakynthinos S. Heart binmarkers as prognostic tools for chronic thromboembolic pulmonary hypertension: a step forward by the fatty acid-binding protein [ J ]. Eur Respir J, 2008,31 (5) : 915 -917.
